Village Compounding Pharmacy

Form 483 issued March 31, 2020 · Houston, Texas

Inspection
Mar 20 – Mar 31, 2020
Investigator
Jason R. Caballero
Observations
2
Pages
2
FEI number
3007003644

In short: On March 31, 2020, FDA issued a Form 483 with 2 observations to Village Compounding Pharmacy in Houston, Texas (FEI 3007003644) after an inspection that ran Mar 20 – Mar 31, 2020. The investigator was Jason R. Caballero. Most observations concern facilities & equipment; the most-cited regulation is 21 CFR 211.42 (design and construction features).

At a glance

2 of 2 observations on this 483 concern facilities & equipment.

Facilities & equipment2

Most cited: 21 CFR 211.42 (2×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Aseptic processing areas are deficient regarding the system for cleaning and disinfecting the room and equipment…

  2. 02

    Observation 2: scanned text, readable in the full document.

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Village Compounding Pharmacy?

FDA listed 2 observations on this Form 483, mostly about facilities & equipment. The most-cited regulation is 21 CFR 211.42 (design and construction features). The opening words of each observation are shown on this page.

Who inspected Village Compounding Pharmacy?

Jason R. Caballero is named on this Form 483, for the inspection of Mar 20 – Mar 31, 2020. Each investigator has a profile showing what they cite most.

When was Village Compounding Pharmacy inspected by FDA?

The inspection ran Mar 20 – Mar 31, 2020, and the Form 483 is dated March 31, 2020.

How do I get the full Form 483 for Village Compounding Pharmacy?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free